Icon

XEGLYZE (nda206966)- (0.74%)

ABAMETAPIR HATCHTECH
0.74%
No No
2034-Dec-17 2025-Jul-24
None None
None No
XEGLYZE is a pediculicide indicated for the topical treatment of head lice infestation in patients 6 months of age and older. XEGLYZE should be used in the context of an overall lice management program: • Wash (with hot water) or dry-clean all recently worn clothing, hats, used bedding and towels • Wash personal care items such as combs, brushes and hair clips in hot water • Use a fine-tooth comb or special nit comb to remove dead lice and nits.
0 0 0
Total Other Developers None
Drugs with Suitability No
0.74% ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.